BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25373456)

  • 1. Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.
    Lourenço N; Hélias-Rodzewicz Z; Bachet JB; Brahimi-Adouane S; Jardin F; Tran van Nhieu J; Peschaud F; Martin E; Beauchet A; Chibon F; Emile JF
    Mol Cancer; 2014 Nov; 13():246. PubMed ID: 25373456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
    Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors.
    Sabah M; Cummins R; Leader M; Kay E
    Mod Pathol; 2004 Nov; 17(11):1364-71. PubMed ID: 15181453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors.
    Matyakhina L; Bei TA; McWhinney SR; Pasini B; Cameron S; Gunawan B; Stergiopoulos SG; Boikos S; Muchow M; Dutra A; Pak E; Campo E; Cid MC; Gomez F; Gaillard RC; Assie G; Füzesi L; Baysal BE; Eng C; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2938-43. PubMed ID: 17535989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
    Belinsky MG; Skorobogatko YV; Rink L; Pei J; Cai KQ; Vanderveer LA; Riddell D; Merkel E; Tarn C; Eisenberg BL; von Mehren M; Testa JR; Godwin AK
    Genes Chromosomes Cancer; 2009 Oct; 48(10):886-96. PubMed ID: 19585585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
    Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
    Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M
    Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance.
    El-Rifai W; Sarlomo-Rikala M; Andersson LC; Knuutila S; Miettinen M
    Cancer Res; 2000 Jul; 60(14):3899-903. PubMed ID: 10919666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSTT1 copy number gain and ZNF overexpression are predictors of poor response to imatinib in gastrointestinal stromal tumors.
    Lee EJ; Kang G; Kang SW; Jang KT; Lee J; Park JO; Park CK; Sohn TS; Kim S; Kim KM
    PLoS One; 2013; 8(10):e77219. PubMed ID: 24124608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring
    Ohshima K; Nagashima T; Fujiya K; Hatakeyama K; Watanabe Y; Morimoto K; Kamada F; Shimoda Y; Ohnami S; Naruoka A; Serizawa M; Ohnami S; Kenmotsu H; Shiomi A; Tsubosa Y; Bando E; Sugiura T; Sugino T; Terashima M; Uesaka K; Urakami K; Akiyama Y; Yamaguchi K
    Cancer Res Commun; 2023 Apr; 3(4):684-696. PubMed ID: 37377752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations of chromosome 13q in gastrointestinal stromal tumors: analysis of 91 cases by fluorescence in situ hybridization (FISH).
    Zhou W; Zeng X; Liu T
    Diagn Mol Pathol; 2009 Jun; 18(2):72-80. PubMed ID: 19430298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
    Shen YY; Ma XL; Wang M; Zhuang C; Ni B; Tu L; Liu Q; Zhao WY; Cao H
    Cancer Med; 2020 Sep; 9(18):6485-6496. PubMed ID: 32697050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways.
    Veiga I; Silva M; Vieira J; Pinto C; Pinheiro M; Torres L; Soares M; Santos L; Duarte H; Bastos AL; Coutinho C; Dinis J; Lopes C; Teixeira MR
    Genes Chromosomes Cancer; 2010 Feb; 49(2):91-8. PubMed ID: 19847891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.
    Wozniak A; Sciot R; Guillou L; Pauwels P; Wasag B; Stul M; Vermeesch JR; Vandenberghe P; Limon J; Debiec-Rychter M
    Genes Chromosomes Cancer; 2007 Mar; 46(3):261-76. PubMed ID: 17171690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.
    Yamamoto H; Tobo T; Nakamori M; Imamura M; Kojima A; Oda Y; Nakamura N; Takahira T; Yao T; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):791-8. PubMed ID: 19020900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor.
    Zhang Y; Cao H; Wang M; Zhao WY; Shen ZY; Shen DP; Ni XZ; Wu ZY; Shen YY; Song YY
    World J Gastroenterol; 2010 Oct; 16(37):4716-24. PubMed ID: 20872974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation.
    Wilkens L; Benten D; Tchinda J; Brabant G; Pötter E; Dralle H; von Wasielewski R
    Virchows Arch; 2000 Apr; 436(4):312-8. PubMed ID: 10834532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.
    Schaefer IM; Delfs C; Cameron S; Gunawan B; Agaimy A; Ghadimi BM; Haller F
    Hum Pathol; 2014 Jan; 45(1):85-97. PubMed ID: 24157063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation.
    Debiec-Rychter M; Lasota J; Sarlomo-Rikala M; Kordek R; Miettinen M
    Cancer Genet Cytogenet; 2001 Jul; 128(1):24-30. PubMed ID: 11454425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.